---
author: []
related: []
publisher:
  url: 'http://www.alternet.org'
  name: Alternet
  favicon: 'http://www.alternet.org/favicon.ico'
  domain: www.alternet.org
keywords:
  - suboxone
  - addicted
  - drugs
  - opioid
  - buprenorphine
  - alcohol
  - treatment
  - abuse
  - goodrx
  - pharma
description: "Addiction treatment has become big business. If you haven't noticed it yet, investors certainly have. The U.S. Substance Abuse and Mental Health Services Administration projected the market for addiction treatment at about $35 billion for 2014. Since 2006, private equity firms have invested more than $2.2 billion in substance abuse treatment companies."
inLanguage: en
app_links: []
isBasedOnUrl: 'http://www.alternet.org/drugs/how-big-pharma-cashing-addiction-alcohol-and-illicit-drugs'
title: How Big Pharma Is Cashing in on Addiction to Alcohol and Illicit Drugs
datePublished: '2016-03-22T10:09:20.854Z'
dateModified: '2016-03-22T09:35:15.340Z'
sourcePath: _posts/2016-03-22-how-big-pharma-is-cashing-in-on-addiction-to-alcohol-and-ill.md
published: true
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>How Big Pharma Is Cashing in on Addiction to Alcohol and Illicit Drugs</h1><p>Addiction treatment has become big business. If you haven't noticed it yet, investors certainly have. The U.S. Substance Abuse and Mental Health Services Administration projected the market for addiction treatment at about $35 billion for 2014. Since 2006, private equity firms have invested more than $2.2 billion in substance abuse treatment companies.</p><img src="http://www.alternet.org/files/story_images/prescription_drugs.png" /></article>